Literature DB >> 20354355

The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect?

G Occhi1, M L Jaffrain-Rea, G Trivellin, N Albiger, F Ceccato, E De Menis, M Angelini, S Ferasin, A Beckers, F Mantero, C Scaroni.   

Abstract

BACKGROUND: Mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene have been described in about 15% of kindreds with familial isolated pituitary adenomas and in a minority of early onset sporadic pituitary adenomas (PA). Among the AIP mutations reported so far, the R304X (AIPR304X) represents, together with the "Finnish mutation" Q14X, the most common one.
METHODS: Three AIPR304X Italian families, including a newly reported kindred, have been genotyped for 12 genetic markers surrounding the AIP gene in order to look for a potential founder effect in Italy. Disease penetrance and genotype-phenotype correlations were also addressed.
RESULTS: Analysis of chromosome 11' genetic markers revealed a common haplotype in 2 AIPR304X kindreds originating from central Italy. Overall, 17 mutations carriers were identified, including 7 patients and 10 unaffected subjects, respectively, arguing in this case for a disease penetrance of 41%. Mean age at diagnosis was 19.1±6.7 yr old, with females tending to be older than males. Though most PA were somatotropinomas (6/7), a great variability in disease severity was observed, even between subjects sharing the same at-risk haplotype.
CONCLUSION: These data provide strong evidence for a new founder effect of the AIPR304X mutation in central Italy and the observed variations in disease severity point out the role of additional genetic or environmental factors in such kindreds.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20354355     DOI: 10.1007/BF03350345

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

1.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

Review 2.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

3.  Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma.

Authors:  S K Khoo; R Pendek; R Nickolov; D C Luccio-Camelo; T L Newton; A Massie; D Petillo; J Menon; D Cameron; B T Teh; S-P Chan
Journal:  Endocr Relat Cancer       Date:  2009-05-14       Impact factor: 5.678

4.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

5.  Aryl hydrocarbon receptor-interacting protein and acromegaly.

Authors:  Lauri A Aaltonen
Journal:  Horm Res       Date:  2007-12-10

6.  Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.

Authors:  Marianthi Georgitsi; Anniina Raitila; Auli Karhu; Karoliina Tuppurainen; Markus J Mäkinen; Outi Vierimaa; Ralf Paschke; Wolfgang Saeger; Rob B van der Luijt; Timo Sane; Mercedes Robledo; Ernesto De Menis; Robert J Weil; Anna Wasik; Grzegorz Zielinski; Olga Lucewicz; Jan Lubinski; Virpi Launonen; Pia Vahteristo; Lauri A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

7.  The tyrosine kinase receptor RET interacts in vivo with aryl hydrocarbon receptor-interacting protein to alter survivin availability.

Authors:  Manuela Vargiolu; Daniela Fusco; Ivana Kurelac; Dietmar Dirnberger; Ralf Baumeister; Isabella Morra; Antonio Melcarne; Roberto Rimondini; Giovanni Romeo; Elena Bonora
Journal:  J Clin Endocrinol Metab       Date:  2009-04-14       Impact factor: 5.958

8.  Isolated familial somatotropinomas: clinical features and analysis of the MEN1 gene.

Authors:  Ernesto De Menis; Toni R Prezant
Journal:  Pituitary       Date:  2002-01       Impact factor: 4.107

9.  Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.

Authors:  Marie-Lise Jaffrain-Rea; Mariolina Angelini; Donatella Gargano; Maria A Tichomirowa; Adrian F Daly; Jean-François Vanbellinghen; Emanuela D'Innocenzo; Anne Barlier; Felice Giangaspero; Vincenzo Esposito; Luca Ventura; Antonietta Arcella; Marily Theodoropoulou; Luciana A Naves; Carmen Fajardo; Sabina Zacharieva; Vincent Rohmer; Thierry Brue; Alberto Gulino; Giampaolo Cantore; Edoardo Alesse; Albert Beckers
Journal:  Endocr Relat Cancer       Date:  2009-06-25       Impact factor: 5.678

10.  Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.

Authors:  Laure Cazabat; Rossella Libè; Karine Perlemoine; Fernande René-Corail; Nelly Burnichon; Anne-Paule Gimenez-Roqueplo; Laurence Dupasquier-Fediaevsky; Xavier Bertagna; Eric Clauser; Philippe Chanson; Jérôme Bertherat; Marie-Laure Raffin-Sanson
Journal:  Eur J Endocrinol       Date:  2007-07       Impact factor: 6.664

View more
  17 in total

1.  Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?

Authors:  Sema Yarman; Yeliz Duvarci Ogret; Fatma Savran Oguz
Journal:  Genet Test Mol Biomarkers       Date:  2015-05-04

2.  The role of AIP mutations in pituitary adenomas: 10 years on.

Authors:  Adrian F Daly; Albert Beckers
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

3.  Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up.

Authors:  F Ceccato; G Occhi; N M Albiger; S Rizzati; S Ferasin; G Trivellin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

4.  Gene mutations in Cushing's disease.

Authors:  Qi Xiong; Wei Ge
Journal:  Biomed Rep       Date:  2016-07-29

5.  A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.

Authors:  Takeo Iwata; Shozo Yamada; Junko Ito; Naoko Inoshita; Noriko Mizusawa; Shinji Ono; Katsuhiko Yoshimoto
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

6.  Familial acromegaly due to aryl hydrocarbon receptor-interacting protein (AIP) gene mutation in a Turkish cohort.

Authors:  Mutlu Niyazoglu; Muge Sayitoglu; Sinem Firtina; Esra Hatipoglu; Nurperi Gazioglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

Review 7.  Familial isolated pituitary adenomas: an emerging clinical entity.

Authors:  F Martucci; G Trivellin; M Korbonits
Journal:  J Endocrinol Invest       Date:  2012-12       Impact factor: 4.256

Review 8.  The AIP (aryl hydrocarbon receptor-interacting protein) gene and its relation to the pathogenesis of pituitary adenomas.

Authors:  Catrin Lloyd; Ashley Grossman
Journal:  Endocrine       Date:  2013-12-24       Impact factor: 3.633

Review 9.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

10.  AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.

Authors:  Claudia Ramírez-Rentería; Laura C Hernández-Ramírez; Lesly Portocarrero-Ortiz; Guadalupe Vargas; Virgilio Melgar; Etual Espinosa; Ana Laura Espinosa-de-Los-Monteros; Ernesto Sosa; Baldomero González; Sergio Zúñiga; Martina Unterländer; Joachim Burger; Karen Stals; Anne-Marie Bussell; Sian Ellard; Mary Dang; Donato Iacovazzo; Sonal Kapur; Plamena Gabrovska; Serban Radian; Federico Roncaroli; Márta Korbonits; Moisés Mercado
Journal:  Endocrine       Date:  2016-03-31       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.